ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2016; 6(8): 083-089


Protective effect of Cordia boissieri A. DC. (Boraginaceae) on metabolic syndrome

Asmaa I. Owis, Amira M. Abo-youssef, Ahmed H. Osman.



Abstract
Download PDF Post

Increased fructose ingestion has been linked to obesity, hyperglycemia, dyslipidemia, and hypertension associated with metabolic syndrome. Cordia boissieri A. DC. (Boraginaceae) is a slow growing beautiful plant, used traditionally as herbal remedy by diabetic Hispanic women in the Southwestern USA. The present study aimed to elucidate the toxicity and the possible protective effect of ethyl acetate extract of C. boissieri leaves on metabolic syndrome. Three groups of rats were fed on fructose-enriched diet for 14 weeks. One group served as fructose-enriched diet control, while the remaining groups were treated with metformin (10 mg/kg/day) and ethyl acetate extract (200 mg/kg/day) during the last 4 weeks. A fourth group was fed on normal laboratory diet. At the end of the experiment, blood samples were withdrawn for the estimation of metabolic syndrome-related markers and liver samples were subjected to histopathological and immunohistochemical examination. Ethyl acetate extract attenuated most of the changes associated with MS as marked by improved insulin sensitivity, glucose tolerance, kidney function, lipid profiles and reduced oxidative stress and inflammation. The present study provides evidence of the potential protective effect of C. boissieri against metabolic syndrome.

Key words: Cordia boissieri, Boraginaceae; metabolic syndrome, ethyl aetate.







Bibliomed Article Statistics

26
25
40
31
34
42
48
20
27
38
35
3
R
E
A
D
S

7

11

16

16

11

18

11

7

15

11

8

6
D
O
W
N
L
O
A
D
S
010203040506070809101112
2025

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.